Search for:

Donate SHARE:

Who we are
Our Mission
Polio Endgame Strategy
GPEI Strategy 2022-2026
Integration
Surveillance
Routine Immunization
Supplementary Immunization
Targeted Mop-up Campaigns
Partners
GPEI Lessons Learned Project
GPEI History Project
Governance and Structure
Polio Oversight Board
Independent Monitoring Board
IMB Members
Reports
Meetings
Global Polio Partners Group
Transition IMB
Polio Today
Polio + Prevention
The Virus
Variant Poliovirus (cVDPV)
The Vaccines
IPV
OPV
The Communities
History of Polio
Polio this week
Wild poliovirus list
Variant Polio (cVDPV) Cases
Public Health Emergency status
Surveillance Indicators
The Global Polio Laboratory Network
Outbreak Preparedness & Response
Preparing for a Polio-Free World
OPV Cessation
Containment
Certification
Global Certification Commission
Regional Certification Commission
Polio Post-Certification Strategy
Transition Planning
Country Transition Planning
Global and Regional Transition Planning
Capturing and sharing lessons learned
FAQ
Where We Work
Endemic Countries
Afghanistan
Pakistan
Outbreak Countries
Key At-Risk Countries
Africa Kicks Out Wild Polio
Polio-Free Countries
Financing
Financial Needs
Polio eradication pledging moment 18 October 2022
Investment Case 2022 – 2026
Financial Resource Requirements
GPEI Budget 2023
GPEI Budget 2022
2020-2023 outbreak budget monitoring
Archived Budgets (2003-2021)
Donors
Historical Contributions 1988-2022
Other Contributions
Expenditure Information
Annual Expenditure Reports
WHO and UNICEF Financing Portals
Donate
Gender
Gender
Gender Equality Strategy
GPEI Gender Infographics
FAQ – Gender and Polio Eradication
Polio Gender Champions
Former Gender Champions
Voices from the Field
Women Leaders
News
News Stories
GPEI Media Centre
Newsletter
Subscribe
Tools
Resources for Polio Eradicators
GPEI Tools, Protocols and Guidelines
Communication for Eradication Strategies
Library
Policy + Reports
Declarations and Resolutions
Reports to WHO Governing Bodies
Global Polio Laboratory Network Reports & Publications
IMB Resources
Reports
Meetings
TIMB Resources
TIMB Reports
TIMB Meetings
Annual Reports
Semi-Annual Status Reports
Advisory Reports
SAGE
Technical Advisory Groups
Advisory Committee on Poliomyelitis Eradication
Containment Advisory Group
Certification Reports
Global Certification Commission
Regional Certification Commission
WHO Weekly Epidemiological Record
Research + Innovation
OPV new developments
Affordable IPV
Vaccine-derived Polioviruses: Managing the risks
Antivirals
Clinical Trials and Seroprevalence Surveys
Research Publications
Polio Research Committee
Grants and Collaborations
Polio Pipeline
Multimedia
Photos
Photo Essays
Photo Collections
Videos

A word from the Chair: 2023 – Aiming for Success through Ongoing Analysis of Global Effort

Rigorous independent review to assess status to meeting end-2023 critical goals

Polio programme provides vital support to nationwide measles vaccination in Afghanistan

21 March 2023

Rotary International President insists Rotarians have to finish the job of eradicating polio

Rotary International President, Jennifer Jones, is on a brief tour of London. Speaking at the House of Commons she said that Rotary had to deliver on its promise to the children of the world that it would help to eradicate polio.

Eastern Mediterranean health leaders call for redoubled efforts for a defining year for polio

On Tuesday 28 February 2023, ministers and high-level delegates from across the Eastern Mediterranean Region participated in the seventh meeting of the Regional Subcommittee for Polio Eradication and Outbreaks.

Confidence in surveillance essential for certifying a polio-free world

Latest recommendations from independent global certification body

This is what lab leaders look like: voices of women leading lab innovations to end polio

In the polio eradication programme, women are forces to be reckoned with. They play important and integral roles at all levels of the programme. We got the perspectives of four women from WHO EMRO who tap into digital innovations to shape decision-making

Filter

Type

At-risk countries

Broader benefits of the polio programme

Certification

Circulating vaccine-derived poliovirus

Containment

COVID-19

Endemic countries

Eradication

Expanded Programme on Immunization - EPI

Financing and donors

Gender

GPEI partners

Henrietta Lacks

Inactivated Polio Vaccine (IPV)

Innovation

International Women's Day

Israel

Japan

Madagascar

Malawi

Mozambique

nOPV2

occupied Palestinian territory

Oral Polio Vaccine (OPV)

Outbreak countries

Outbreak response

Polio Endgame Strategy

Reaching the Last Mile

Research

Routine immunization

Social mobilization

Surveillance

Transition planning

Vaccination campaigns

Vaccines

World Polio Day

WPV

Countries

Afghanistan

Africa

Algeria

Angola

Asia

Australia

Bangladesh

Benin

Botswana

Burkina Faso

Burundi

Cambodia

Cameroon

Central Africa

Central African Republic

Chad

Congo

Cote d'lvoire

Democratic Republic of the Congo

Egypt

Ethiopia

Europe

Gambia

Guinea

Horn of Africa

India

Indonesia

Iraq

Japan

Jordan

Kenya

Kyrgyzstan

Lake Chad Region

Lao People’s Democratic Republic

Lebanon

Liberia

Madagascar

Mali

Mauritania

Middle East

Mozambique

Niger

Nigeria

Pakistan

Papua New Guinea

Republic of Korea

Saudi Arabia

Senegal

Sierra Leone

Somalia

South Sudan

Sudan

Switzerland

Syrian Arab Republic

Türkiye

Ukraine

United Kingdom

United States

West Africa

Yemen

Clear

News

To subscribe to PolioNews, click here.

28/07/2000

Polio Campaign Monitoring

Independent polio campaign monitoring is carried out to assess the quality and impact of supplementary immunization activities. It is critical to guiding any necessary mid-course corrections if gaps or problems are found. The basic elements of monitor...

28/07/2000

Scientific Meeting on Vaccine-Derived Polioviruses (VDPVs)

VDPVs and their Implications – State of the Art

28/07/2000

Vaccine-Derived Polioviruses: Managing the Risks

This area of research focuses on managing the long-term risks of polio relating to vaccine-derived polioviruses (VDPVs) and vaccine-associated paralytic polio (VAPP) in the post-eradication era. It includes managing the risks through the eventual cessation...